{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["VCAM-1 targeting", "cationic liposomes", "miR-126 delivery", "vascular endothelial inflammation treatment"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37242620", "DateRevised": {"Year": "2023", "Month": "05", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "04", "Day": "30"}], "Language": ["eng"], "ELocationID": ["1379", "10.3390/pharmaceutics15051379"], "Journal": {"ISSN": "1999-4923", "JournalIssue": {"Volume": "15", "Issue": "5", "PubDate": {"Year": "2023", "Month": "Apr", "Day": "30"}}, "Title": "Pharmaceutics", "ISOAbbreviation": "Pharmaceutics"}, "ArticleTitle": "MiR-126-Loaded Immunoliposomes against Vascular Endothelial Inflammation In Vitro and Vivo Evaluation.", "Abstract": {"AbstractText": ["Due to the accompaniment of vascular endothelial inflammation during the occurrence and development of cardiovascular diseases (CVD), treatment modalities against vascular endothelial inflammation have been intensively investigated for CVD prevention and/or treatment. Vascular cell adhesion molecule-1 (VCAM-1) is a typical transmembrane inflammatory protein specifically expressed by inflammatory vascular endothelial. By inhibiting VCAM-1 expression through the miR-126 mediated pathway, vascular endothelial inflammation can be efficiently relieved. Inspired by this, we developed a miR-126-loaded immunoliposome with VCAM-1 monoclonal antibody (VCAM<sub>ab</sub>) decorated at its surface. This immunoliposome can be directly targeted to VCAM-1 at the inflammatory vascular endothelial membrane surface and achieve highly efficient treatment against inflammation response. The cellular experiment results showed the immunoliposome had a higher uptake rate towards inflammatory human vein endothelial cells (HUVECs) and can significantly downregulate the VCAM-1 expression level of inflammatory HUVECs. In vivo investigation further demonstrated that this immunoliposome displayed a higher accumulation rate at vascular inflammatory dysfunction sites than its non-VCAM<sub>ab</sub>-modified counterpart. These results suggest that this novel nanoplatform can effectively deliver miR-126 to vascular inflammatory endothelium, opening a new avenue for the safe and effective delivery of miRNA for potential clinical application."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The State Key Laboratory of Functions and Applications of Medicinal Plants, School of Pharmaceutical Sciences, Guizhou Medical University, University Town, Guian New District, Guiyang 550025, China."}, {"Identifier": [], "Affiliation": "The Department of Pharmacology of Materia Medica (The High Efficacy Application of Natural Medicinal Resources Engineering Center of Guizhou Province and The High Educational Key Laboratory of Guizhou Province for Natural Medicinal Pharmacology and Druggability), School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550031, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Optimal Utilization of Natural Medicine Resources (The Union Key Laboratory of Guiyang City-Guizhou Medical University), School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550031, China."}], "LastName": "Tang", "ForeName": "Yongyu", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The State Key Laboratory of Functions and Applications of Medicinal Plants, School of Pharmaceutical Sciences, Guizhou Medical University, University Town, Guian New District, Guiyang 550025, China."}, {"Identifier": [], "Affiliation": "The Department of Pharmacology of Materia Medica (The High Efficacy Application of Natural Medicinal Resources Engineering Center of Guizhou Province and The High Educational Key Laboratory of Guizhou Province for Natural Medicinal Pharmacology and Druggability), School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550031, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Optimal Utilization of Natural Medicine Resources (The Union Key Laboratory of Guiyang City-Guizhou Medical University), School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550031, China."}], "LastName": "Chen", "ForeName": "Ying", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The State Key Laboratory of Functions and Applications of Medicinal Plants, School of Pharmaceutical Sciences, Guizhou Medical University, University Town, Guian New District, Guiyang 550025, China."}, {"Identifier": [], "Affiliation": "The Department of Pharmacology of Materia Medica (The High Efficacy Application of Natural Medicinal Resources Engineering Center of Guizhou Province and The High Educational Key Laboratory of Guizhou Province for Natural Medicinal Pharmacology and Druggability), School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550031, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Optimal Utilization of Natural Medicine Resources (The Union Key Laboratory of Guiyang City-Guizhou Medical University), School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550031, China."}], "LastName": "Guo", "ForeName": "Qianqian", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The State Key Laboratory of Functions and Applications of Medicinal Plants, School of Pharmaceutical Sciences, Guizhou Medical University, University Town, Guian New District, Guiyang 550025, China."}, {"Identifier": [], "Affiliation": "The Department of Pharmacology of Materia Medica (The High Efficacy Application of Natural Medicinal Resources Engineering Center of Guizhou Province and The High Educational Key Laboratory of Guizhou Province for Natural Medicinal Pharmacology and Druggability), School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550031, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Optimal Utilization of Natural Medicine Resources (The Union Key Laboratory of Guiyang City-Guizhou Medical University), School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550031, China."}], "LastName": "Zhang", "ForeName": "Lidan", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The State Key Laboratory of Functions and Applications of Medicinal Plants, School of Pharmaceutical Sciences, Guizhou Medical University, University Town, Guian New District, Guiyang 550025, China."}, {"Identifier": [], "Affiliation": "The Department of Pharmacology of Materia Medica (The High Efficacy Application of Natural Medicinal Resources Engineering Center of Guizhou Province and The High Educational Key Laboratory of Guizhou Province for Natural Medicinal Pharmacology and Druggability), School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550031, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Optimal Utilization of Natural Medicine Resources (The Union Key Laboratory of Guiyang City-Guizhou Medical University), School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550031, China."}], "LastName": "Liu", "ForeName": "Huanhuan", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The State Key Laboratory of Functions and Applications of Medicinal Plants, School of Pharmaceutical Sciences, Guizhou Medical University, University Town, Guian New District, Guiyang 550025, China."}, {"Identifier": [], "Affiliation": "The Department of Pharmacology of Materia Medica (The High Efficacy Application of Natural Medicinal Resources Engineering Center of Guizhou Province and The High Educational Key Laboratory of Guizhou Province for Natural Medicinal Pharmacology and Druggability), School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550031, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Optimal Utilization of Natural Medicine Resources (The Union Key Laboratory of Guiyang City-Guizhou Medical University), School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550031, China."}], "LastName": "Wang", "ForeName": "Sibu", "Initials": "S"}, {"Identifier": ["0000-0002-8768-5633"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The State Key Laboratory of Functions and Applications of Medicinal Plants, School of Pharmaceutical Sciences, Guizhou Medical University, University Town, Guian New District, Guiyang 550025, China."}, {"Identifier": [], "Affiliation": "The Department of Pharmacology of Materia Medica (The High Efficacy Application of Natural Medicinal Resources Engineering Center of Guizhou Province and The High Educational Key Laboratory of Guizhou Province for Natural Medicinal Pharmacology and Druggability), School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550031, China."}], "LastName": "Wu", "ForeName": "Xingjie", "Initials": "X"}, {"Identifier": ["0000-0002-4333-9106"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The State Key Laboratory of Functions and Applications of Medicinal Plants, School of Pharmaceutical Sciences, Guizhou Medical University, University Town, Guian New District, Guiyang 550025, China."}, {"Identifier": [], "Affiliation": "The Department of Pharmacology of Materia Medica (The High Efficacy Application of Natural Medicinal Resources Engineering Center of Guizhou Province and The High Educational Key Laboratory of Guizhou Province for Natural Medicinal Pharmacology and Druggability), School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550031, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Optimal Utilization of Natural Medicine Resources (The Union Key Laboratory of Guiyang City-Guizhou Medical University), School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550031, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Endemic and Ethnic Diseases of Ministry of Education, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Shen", "ForeName": "Xiangchun", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The State Key Laboratory of Functions and Applications of Medicinal Plants, School of Pharmaceutical Sciences, Guizhou Medical University, University Town, Guian New District, Guiyang 550025, China."}, {"Identifier": [], "Affiliation": "The Department of Pharmacology of Materia Medica (The High Efficacy Application of Natural Medicinal Resources Engineering Center of Guizhou Province and The High Educational Key Laboratory of Guizhou Province for Natural Medicinal Pharmacology and Druggability), School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550031, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Optimal Utilization of Natural Medicine Resources (The Union Key Laboratory of Guiyang City-Guizhou Medical University), School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550031, China."}], "LastName": "Tao", "ForeName": "Ling", "Initials": "L"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceutics", "NlmUniqueID": "101534003", "ISSNLinking": "1999-4923"}, "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that influenced the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Pogosova N., Kotseva K., De Bacquer D., von K\u00e4nel R., De Smedt D., Bruthans J., Dolzhenko M. Psychosocial risk factors in relation to other cardiovascular risk factors in coronary heart disease: Results from the EUROASPIRE IV survey. A registry from the European Society of Cardiology. Eur. J. Prev. Cardiol. 2017;24:1371\u20131380. doi: 10.1177/2047487317711334.", "ArticleIdList": ["10.1177/2047487317711334", "28534422"]}, {"Citation": "Steyers C.M., Miller F.J. Endothelial Dysfunction in Chronic Inflammatory Diseases. Int. J. Mol. Sci. 2014;15:11324\u201311349. doi: 10.3390/ijms150711324.", "ArticleIdList": ["10.3390/ijms150711324", "PMC4139785", "24968272"]}, {"Citation": "Castro-Ferreira R., Cardoso R., Leite-Moreira A., Mansilha A. The Role of Endothelial Dysfunction and Inflammation in Chronic Venous Disease. Ann. Vasc. Surg. 2018;46:380\u2013393. doi: 10.1016/j.avsg.2017.06.131.", "ArticleIdList": ["10.1016/j.avsg.2017.06.131", "28688874"]}, {"Citation": "Mozos I., Malainer C., Horba\u0144czuk J., Gug C., Stoian D., Luca C.T., Atanasov A.G. Inflammatory Markers for Arterial Stiffness in Cardiovascular Diseases. Front. Immunol. 2017;8:1058. doi: 10.3389/fimmu.2017.01058.", "ArticleIdList": ["10.3389/fimmu.2017.01058", "PMC5583158", "28912780"]}, {"Citation": "Chen Y.-C., Gad S.F., Chobisa D., Li Y., Yeo Y. Local drug delivery systems for inflammatory diseases: Status quo, challenges, and opportunities. J. Control. Release. 2021;330:438\u2013460. doi: 10.1016/j.jconrel.2020.12.025.", "ArticleIdList": ["10.1016/j.jconrel.2020.12.025", "33352244"]}, {"Citation": "Yao R.-Q., Ren C., Xia Z.-F., Yao Y.-M. Organelle-specific autophagy in inflammatory diseases: A potential therapeutic target underlying the quality control of multiple organelles. Autophagy. 2021;17:385\u2013401. doi: 10.1080/15548627.2020.1725377.", "ArticleIdList": ["10.1080/15548627.2020.1725377", "PMC8007140", "32048886"]}, {"Citation": "Hannequin P., Liehn J.C., Maes B., Delisle M.J. Multivariate analysis in solitary cold thyroid nodules for the diagnosis of malignancy. Eur. J. Cancer Clin. Oncol. 1988;24:881\u2013888. doi: 10.1016/0277-5379(88)90197-6.", "ArticleIdList": ["10.1016/0277-5379(88)90197-6", "3169093"]}, {"Citation": "Fish J.E., Santoro M.M., Morton S.U., Yu S., Yeh R.-F., Wythe J.D., Ivey K.N., Bruneau B.G., Stainier D.Y.R., Srivastava D. miR-126 Regulates Angiogenic Signaling and Vascular Integrity. Dev. Cell. 2008;15:272\u2013284. doi: 10.1016/j.devcel.2008.07.008.", "ArticleIdList": ["10.1016/j.devcel.2008.07.008", "PMC2604134", "18694566"]}, {"Citation": "Kumari R., Kumar S., Kant R. Role of circulating miRNAs in the pathophysiology of CVD: As a potential biomarker. Gene Rep. 2018;13:146\u2013150. doi: 10.1016/j.genrep.2018.10.003.", "ArticleIdList": ["10.1016/j.genrep.2018.10.003"]}, {"Citation": "Wu P., Wu Y., Liu C.-C., Liu L.-W., Ma F.-F., Wu X.-Y., Wu M., Hang Y.-Y., Chen J.-Q., Shao Z.-Q., et al. Identification of Arbuscular Mycorrhiza (AM)-Responsive microRNAs in Tomato. Front. Plant Sci. 2016;7:429. doi: 10.3389/fpls.2016.00429.", "ArticleIdList": ["10.3389/fpls.2016.00429", "PMC4814767", "27066061"]}, {"Citation": "Wu X., Yang H., Li W., Tao L., Wang Q., Jin Y., Sun X., Shen X. Multiparametric miRNAs profiling by polymerization induced fluorescence-off amplification for acute myocardial infarction diagnosis. Sens. Actuators B Chem. 2021;344:130315. doi: 10.1016/j.snb.2021.130315.", "ArticleIdList": ["10.1016/j.snb.2021.130315"]}, {"Citation": "Zhou S.-S., Jin J.-P., Wang J.-Q., Zhang Z.-G., Freedman J.H., Zheng Y., Cai L. miRNAS in cardiovascular diseases: Potential biomarkers, therapeutic targets and challenges. Acta Pharmacol. Sin. 2018;39:1073\u20131084. doi: 10.1038/aps.2018.30.", "ArticleIdList": ["10.1038/aps.2018.30", "PMC6289363", "29877320"]}, {"Citation": "Sun C., Alkhoury K., Wang Y.I., Foster G.A., Radecke C.E., Tam K., Edwards C.M., Facciotti M.T., Armstrong E.J., Knowlton A.A., et al. IRF-1 and miRNA126 Modulate VCAM-1 Expression in Response to a High-Fat Meal. Circ. Res. 2012;111:1054\u20131064. doi: 10.1161/CIRCRESAHA.112.270314.", "ArticleIdList": ["10.1161/CIRCRESAHA.112.270314", "PMC3810165", "22874466"]}, {"Citation": "Harris T.A., Yamakuchi M., Ferlito M., Mendell J.T., Lowenstein C.J. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc. Natl. Acad. Sci. USA. 2008;105:1516\u20131521. doi: 10.1073/pnas.0707493105.", "ArticleIdList": ["10.1073/pnas.0707493105", "PMC2234176", "18227515"]}, {"Citation": "Liu B., Sun Y.L., Xu J.B., Wang X.J., Sun Y.B. Angiopoietin-1 alleviates LPS-induced inflammatory injury by up-regulation of miR-126 in pancreas cell line HPDE6-C7. Int. J. Clin. Exp. Pathol. 2017;10:11450\u201311460.", "ArticleIdList": ["PMC6966023", "31966500"]}, {"Citation": "Yu C.D., Miao W.H., Zhang Y.Y., Zou M.J., Yan X.F. Inhibition of miR-126 protects chondrocytes from IL-1\u03b2 induced inflammation via upregulation of Bcl-2. Bone Jt. Res. 2018;7:414\u2013421. doi: 10.1302/2046-3758.76.BJR-2017-0138.R1.", "ArticleIdList": ["10.1302/2046-3758.76.BJR-2017-0138.R1", "PMC6035362", "30034795"]}, {"Citation": "Huang F., Fang Z.-F., Hu X.-Q., Tang L., Zhou S.-H., Huang J.-P. Overexpression of miR-126 promotes the differentiation of mesenchymal stem cells toward endothelial cells via activation of PI3K/Akt and MAPK/ERK pathways and release of paracrine factors. Biol. Chem. 2013;394:1223\u20131233. doi: 10.1515/hsz-2013-0107.", "ArticleIdList": ["10.1515/hsz-2013-0107", "23729621"]}, {"Citation": "Zuo K., Zhi K., Zhang X., Lu C., Wang S., Li M., He B. A Dysregulated MicroRNA-26a/EphA2 Axis Impairs Endothelial Progenitor Cell Function via the p38 MAPK/VEGF Pathway. Cell Physiol. Biochem. 2015;35:477\u2013488. doi: 10.1159/000369713.", "ArticleIdList": ["10.1159/000369713", "25613580"]}, {"Citation": "Yan Y., Liu X.-Y., Lu A., Wang X.-Y., Jiang L.-X., Wang J.-C. Non-viral vectors for RNA delivery. J. Control. Release. 2022;342:241\u2013279. doi: 10.1016/j.jconrel.2022.01.008.", "ArticleIdList": ["10.1016/j.jconrel.2022.01.008", "PMC8743282", "35016918"]}, {"Citation": "Yuba E., Kado Y., Kasho N., Harada A. Cationic lipid potentiated the adjuvanticity of polysaccharide derivative-modified liposome vaccines. J. Control. Release. 2022 doi: 10.1016/j.jconrel.2022.10.016. in press.", "ArticleIdList": ["10.1016/j.jconrel.2022.10.016", "36244508"]}, {"Citation": "Saw P.E., Song E.-W. siRNA therapeutics: A clinical reality. Sci. China. 2020;63:485\u2013500. doi: 10.1007/s11427-018-9438-y.", "ArticleIdList": ["10.1007/s11427-018-9438-y", "31054052"]}, {"Citation": "Sui L., Wang M., Han Q., Yu L., Zhang L., Zheng L., Lian J., Zhang J., Valverde P., Xu Q., et al. A novel Lipidoid-MicroRNA formulation promotes calvarial bone regeneration. Biomaterials. 2018;177:88\u201397. doi: 10.1016/j.biomaterials.2018.05.038.", "ArticleIdList": ["10.1016/j.biomaterials.2018.05.038", "PMC6019203", "29886386"]}, {"Citation": "Hattori Y., Tamaki K., Ozaki K.-I., Kawano K., Onishi H. Optimized combination of cationic lipids and neutral helper lipids in cationic liposomes for siRNA delivery into the lung by intravenous injection of siRNA lipoplexes. J. Drug Deliv. Sci. Technol. 2019;52:1042\u20131050. doi: 10.1016/j.jddst.2019.06.016.", "ArticleIdList": ["10.1016/j.jddst.2019.06.016"]}, {"Citation": "Li M., Li S., Li Y., Li X., Yang G., Li M., Xie Y., Su W., Wu J., Jia L., et al. Cationic liposomes co-deliver chemotherapeutics and siRNA for the treatment of breast cancer. Eur. J. Med. Chem. 2022;233:114198. doi: 10.1016/j.ejmech.2022.114198.", "ArticleIdList": ["10.1016/j.ejmech.2022.114198", "35245829"]}, {"Citation": "Pirollo K.F., Rait A., Zhou Q., Zhang X.-Q., Zhou J., Kim C.-S., Benedict W.F., Chang E.H. Tumor-Targeting Nanocomplex Delivery of Novel Tumor Suppressor RB94 Chemosensitizes Bladder Carcinoma Cells In vitro and In vivo. Clin. Cancer Res. 2008;14:2190\u20132198. doi: 10.1158/1078-0432.CCR-07-1951.", "ArticleIdList": ["10.1158/1078-0432.CCR-07-1951", "PMC4448145", "18381961"]}, {"Citation": "Misso G., Di Martino M.T., De Rosa G., Farooqi A.A., Lombardi A., Campani V., Zarone M.R., Gull\u00e0 A., Tagliaferri P., Tassone P., et al. Mir-34: A New Weapon Against Cancer? Mol. Ther.-Nucleic Acids. 2014;3:e195. doi: 10.1038/mtna.2014.47.", "ArticleIdList": ["10.1038/mtna.2014.47", "PMC4222652", "25247240"]}, {"Citation": "Trang P., Wiggins J.F., Daige C.L., Cho C., Omotola M., Brown D., Weidhaas J.B., Bader A.G., Slack F.J. Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice. Mol. Ther. 2011;19:1116\u20131122. doi: 10.1038/mt.2011.48.", "ArticleIdList": ["10.1038/mt.2011.48", "PMC3129804", "21427705"]}, {"Citation": "Kasinski A.L., Kelnar K., Stahlhut C., Orellana E., Zhao J., Shimer E., Dysart S., Chen X., Bader A.G., Slack F.J. A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer. Oncogene. 2015;34:3547\u20133555. doi: 10.1038/onc.2014.282.", "ArticleIdList": ["10.1038/onc.2014.282", "PMC4345154", "25174400"]}, {"Citation": "Weinstein S., Toker I.A., Emmanuel R., Ramishetti S., Hazan-Halevy I., Rosenblum D., Goldsmith M., Abraham A., Benjamini O., Bairey O., et al. Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies. Proc. Natl. Acad. Sci. USA. 2016;113:E16\u2013E22. doi: 10.1073/pnas.1519273113.", "ArticleIdList": ["10.1073/pnas.1519273113", "PMC4711827", "26699502"]}, {"Citation": "Cao W., Li R., Pei X., Chai M., Sun L., Huang Y., Wang J., Barth S., Yu F., He H. Antibody\u2013siRNA conjugates (ARC): Emerging siRNA drug formulation. Med. Drug Discov. 2022;15:100128. doi: 10.1016/j.medidd.2022.100128.", "ArticleIdList": ["10.1016/j.medidd.2022.100128"]}, {"Citation": "Jin S., Sun Y., Liang X., Gu X., Ning J., Xu Y., Chen S., Pan L. Emerging new therapeutic antibody derivatives for cancer treatment. Signal Transduct. Target. Ther. 2022;7:39. doi: 10.1038/s41392-021-00868-x.", "ArticleIdList": ["10.1038/s41392-021-00868-x", "PMC8821599", "35132063"]}, {"Citation": "Sheridan C. With Alnylam\u2019s amyloidosis success, RNAi approval hopes soar. Nat. Biotechnol. 2017;35:995\u2013996. doi: 10.1038/nbt1117-995.", "ArticleIdList": ["10.1038/nbt1117-995", "29121028"]}, {"Citation": "Shah V.N., Pyle L. Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1. N. Engl. J. Med. 2021;385:e69. doi: 10.1056/NEJMc2107661.", "ArticleIdList": ["10.1056/NEJMc2107661", "34758264"]}, {"Citation": "Thapar M., Rudnick S., Bonkovsky H.L. Givosiran, a novel treatment for acute hepatic porphyrias. Expert Rev. Precis. Med. Drug Dev. 2021;6:9\u201318. doi: 10.1080/23808993.2021.1838275.", "ArticleIdList": ["10.1080/23808993.2021.1838275"]}, {"Citation": "Warden B.A., Duell P.B. Inclisiran: A Novel Agent for Lowering Apolipoprotein B\u2013containing Lipoproteins. J. Cardiovasc. Pharmacol. 2021;78:e157\u2013e174. doi: 10.1097/FJC.0000000000001053.", "ArticleIdList": ["10.1097/FJC.0000000000001053", "33990512"]}, {"Citation": "Mamot C., Drummond D.C., Noble C.O., Kallab V., Guo Z., Hong K., Kirpotin D.B., Park J.W. Epidermal Growth Factor Receptor\u2013Targeted Immunoliposomes Significantly Enhance the Efficacy of Multiple Anticancer Drugs In vivo. Cancer Res. 2005;65:11631\u201311638. doi: 10.1158/0008-5472.CAN-05-1093.", "ArticleIdList": ["10.1158/0008-5472.CAN-05-1093", "16357174"]}, {"Citation": "Gosk S., Moos T., Gottstein C., Bendas G. VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo. Biochim. Et Biophys. Acta (BBA)-Biomembr. 2008;1778:854\u2013863. doi: 10.1016/j.bbamem.2007.12.021.", "ArticleIdList": ["10.1016/j.bbamem.2007.12.021", "18211818"]}, {"Citation": "Lee Y.K., Lee T.S., Song I.H., Jeong H.Y., Kang S.J., Kim M.W., Ryu S.H., Jung I.H., Kim J.S., Park Y.S. Inhibition of pulmonary cancer progression by epidermal growth factor receptor-targeted transfection with Bcl-2 and survivin siRNAs. Cancer Gene Ther. 2015;22:335\u2013343. doi: 10.1038/cgt.2015.18.", "ArticleIdList": ["10.1038/cgt.2015.18", "25857361"]}, {"Citation": "Choi K.Y., Correa S., Min J., Li J., Roy S., Laccetti K.H., Dreaden E., Kong S., Heo R., Roh Y.H., et al. Binary Targeting of siRNA to Hematologic Cancer Cells In Vivo Using Layer-by-Layer Nanoparticles. Adv. Funct. Mater. 2019;29:1900018. doi: 10.1002/adfm.201900018.", "ArticleIdList": ["10.1002/adfm.201900018", "PMC6910249", "31839764"]}, {"Citation": "Linghu K.-G., Wu G.-P., Fu L.-Y., Yang H., Li H.-Z., Chen Y., Yu H., Tao L., Shen X.-C. 1,8-Cineole Ameliorates LPS-Induced Vascular Endothelium Dysfunction in Mice via PPAR-\u03b3 Dependent Regulation of NF-\u03baB. Front. Pharmacol. 2019;10:178. doi: 10.3389/fphar.2019.00178.", "ArticleIdList": ["10.3389/fphar.2019.00178", "PMC6423908", "30930772"]}, {"Citation": "Zhou T., Tang X., Zhang W., Feng J., Wu W. Preparation and in vitro and in vivo evaluations of 10-hydroxycamptothecin liposomes modified with stearyl glycyrrhetinate. Drug Deliv. 2019;26:673\u2013679. doi: 10.1080/10717544.2019.1636422.", "ArticleIdList": ["10.1080/10717544.2019.1636422", "PMC6610527", "31266376"]}, {"Citation": "Di Filippo L.D., Duarte J.L., Azambuja J.H., Mancuso R.I., Luiz M.T., Ara\u00fajo V.H.S., Figueiredo I.D., Barretto-de-Souza L., S\u00e1bio R.M., Sasso-Cerri E., et al. Glioblastoma multiforme targeted delivery of docetaxel using bevacizumab-modified nanostructured lipid carriers impair in vitro cell growth and in vivo tumor progression. Int. J. Pharm. 2022;618:121682. doi: 10.1016/j.ijpharm.2022.121682.", "ArticleIdList": ["10.1016/j.ijpharm.2022.121682", "35307470"]}, {"Citation": "Wu J., Li X., Huang L., Jiang S., Tu F., Zhang X., Ma H., Li R., Li C., Li Y., et al. HSPA12B inhibits lipopolysaccharide-induced inflammatory response in human umbilical vein endothelial cells. J. Cell. Mol. Med. 2015;19:544\u2013554. doi: 10.1111/jcmm.12464.", "ArticleIdList": ["10.1111/jcmm.12464", "PMC4369812", "25545050"]}, {"Citation": "Meng Q., Pu L., Lu Q., Wang B., Li S., Liu B., Li F. Morin hydrate inhibits atherosclerosis and LPS-induced endothelial cells inflammatory responses by modulating the NF\u03baB signaling-mediated autophagy. Int. Immunopharmacol. 2021;100:108096. doi: 10.1016/j.intimp.2021.108096.", "ArticleIdList": ["10.1016/j.intimp.2021.108096", "34464886"]}, {"Citation": "Zhao H., Anand A.R., Ganju R.K. Slit2\u2013Robo4 Pathway Modulates Lipopolysaccharide-Induced Endothelial Inflammation and Its Expression Is Dysregulated during Endotoxemia. J. Immunol. 2014;192:385. doi: 10.4049/jimmunol.1302021.", "ArticleIdList": ["10.4049/jimmunol.1302021", "PMC3908786", "24272999"]}, {"Citation": "Griendling K.K., Alexander R.W. Endothelial control of the cardiovascular system: Recent advances. FASEB J. 1996;10:283\u2013292. doi: 10.1096/fasebj.10.2.8641561.", "ArticleIdList": ["10.1096/fasebj.10.2.8641561", "8641561"]}, {"Citation": "Widmer R.J., Lerman A. Endothelial dysfunction and cardiovascular disease. Glob. Cardiol. Sci. Pract. 2014;2014:291\u2013308. doi: 10.5339/gcsp.2014.43.", "ArticleIdList": ["10.5339/gcsp.2014.43", "PMC4352682", "25780786"]}, {"Citation": "Haraldsen G., Kvale D., Lien B., Farstad I.N., Brandtzaeg P. Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells. J. Immunol. 1996;156:2558. doi: 10.4049/jimmunol.156.7.2558.", "ArticleIdList": ["10.4049/jimmunol.156.7.2558", "8786319"]}, {"Citation": "Sima A.V., Stancu C.S., Simionescu M. Vascular endothelium in atherosclerosis. Cell Tissue Res. 2009;335:191\u2013203. doi: 10.1007/s00441-008-0678-5.", "ArticleIdList": ["10.1007/s00441-008-0678-5", "18797930"]}, {"Citation": "Theofilis P., Sagris M., Oikonomou E., Antonopoulos A.S., Siasos G., Tsioufis C., Tousoulis D. Inflammatory Mechanisms Contributing to Endothelial Dysfunction. Biomedicines. 2021;9:781. doi: 10.3390/biomedicines9070781.", "ArticleIdList": ["10.3390/biomedicines9070781", "PMC8301477", "34356845"]}, {"Citation": "Xu S., Ilyas I., Little P.J., Li H., Kamato D., Zheng X., Luo S., Li Z., Liu P., Han J., et al. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies. Pharmacol. Rev. 2021;73:924. doi: 10.1124/pharmrev.120.000096.", "ArticleIdList": ["10.1124/pharmrev.120.000096", "34088867"]}, {"Citation": "Distasio N., Salmon H., Dierick F., Ebrahimian T., Tabrizian M., Lehoux S. VCAM-1-Targeted Gene Delivery Nanoparticles Localize to Inflamed Endothelial Cells and Atherosclerotic Plaques. Adv. Ther. 2021;4:2000196. doi: 10.1002/adtp.202000196.", "ArticleIdList": ["10.1002/adtp.202000196"]}, {"Citation": "Tai H.-C., Chang A.-C., Yu H.-J., Huang C.-Y., Tsai Y.-C., Lai Y.-W., Sun H.-L., Tang C.-H., Wang S.-W. Osteoblast-derived WISP-1 increases VCAM-1 expression and enhances prostate cancer metastasis by down-regulating miR-126. Oncotarget. 2014;5:7589\u20137598. doi: 10.18632/oncotarget.2280.", "ArticleIdList": ["10.18632/oncotarget.2280", "PMC4202146", "25277191"]}, {"Citation": "Xu Q., Luan T., Fu S., Yang J., Jiang C., Xia F. Effects of Pitavastatin on the Expression of VCAM-1 and its Target Gene miR-126 in Cultured Human Umbilical Vein Endothelial Cells. Cardiovasc. Ther. 2014;32:193\u2013197. doi: 10.1111/1755-5922.12081.", "ArticleIdList": ["10.1111/1755-5922.12081", "24870014"]}, {"Citation": "Bai X., Luo J., Zhang X., Han J., Wang Z., Miao J., Bai Y. MicroRNA-126 Reduces Blood-Retina Barrier Breakdown via the Regulation of VCAM-1 and BCL2L11 in Ischemic Retinopathy. Ophthalmic Res. 2017;57:173\u2013185. doi: 10.1159/000454716.", "ArticleIdList": ["10.1159/000454716", "28076855"]}, {"Citation": "Fang X., Cao J., Shen A. Advances in anti-breast cancer drugs and the application of nano-drug delivery systems in breast cancer therapy. J. Drug Deliv. Sci. Technol. 2020;57:101662. doi: 10.1016/j.jddst.2020.101662.", "ArticleIdList": ["10.1016/j.jddst.2020.101662"]}, {"Citation": "Park J.-G., Ryu S.Y., Jung I.-H., Lee Y.-H., Kang K.J., Lee M.-R., Lee M.-N., Sonn S.K., Lee J.H., Lee H., et al. Evaluation of VCAM-1 antibodies as therapeutic agent for atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis. 2013;226:356\u2013363. doi: 10.1016/j.atherosclerosis.2012.11.029.", "ArticleIdList": ["10.1016/j.atherosclerosis.2012.11.029", "23245509"]}, {"Citation": "He F., Wen N., Xiao D., Yan J., Xiong H., Cai S., Liu Z., Liu Y. Aptamer-Based Targeted Drug Delivery Systems: Current Potential and Challenges. Curr. Med. Chem. 2020;27:2189\u20132219. doi: 10.2174/0929867325666181008142831.", "ArticleIdList": ["10.2174/0929867325666181008142831", "30295183"]}, {"Citation": "Meng W., He C., Hao Y., Wang L., Li L., Zhu G. Prospects and challenges of extracellular vesicle-based drug delivery system: Considering cell source. Drug Deliv. 2020;27:585\u2013598. doi: 10.1080/10717544.2020.1748758.", "ArticleIdList": ["10.1080/10717544.2020.1748758", "PMC7178886", "32264719"]}, {"Citation": "Zu H., Gao D. Non-viral Vectors in Gene Therapy: Recent Development, Challenges, and Prospects. AAPS J. 2021;23:78. doi: 10.1208/s12248-021-00608-7.", "ArticleIdList": ["10.1208/s12248-021-00608-7", "PMC8171234", "34076797"]}, {"Citation": "Khan M.I., Hossain M.I., Hossain M.K., Rubel M.H.K., Hossain K.M., Mahfuz A.M.U.B., Anik M.I. Recent Progress in Nanostructured Smart Drug Delivery Systems for Cancer Therapy: A Review. ACS Appl. Bio Mater. 2022;5:971\u20131012. doi: 10.1021/acsabm.2c00002.", "ArticleIdList": ["10.1021/acsabm.2c00002", "35226465"]}, {"Citation": "Tao J.I.N., Ding W.-F., Che X.-H., Chen Y.-C., Chen F., Chen X.-D., Ye X.-L., Xiong S.-B. Optimization of a cationic liposome-based gene delivery system for the application of miR-145 in anticancer therapeutics. Int. J. Mol. Med. 2016;37:1345\u20131354. doi: 10.3892/ijmm.2016.2530.", "ArticleIdList": ["10.3892/ijmm.2016.2530", "26986502"]}, {"Citation": "Haghiralsadat F., Amoabediny G., Naderinezhad S., Nazmi K., De Boer J.P., Zandieh-Doulabi B., Forouzanfar T., Helder M.N. EphA2 Targeted Doxorubicin-Nanoliposomes for Osteosarcoma Treatment. Pharm. Res. 2017;34:2891\u20132900. doi: 10.1007/s11095-017-2272-6.", "ArticleIdList": ["10.1007/s11095-017-2272-6", "29110283"]}, {"Citation": "Hei Y., Teng B., Zeng Z., Zhang S., Li Q., Pan J., Luo Z., Xiong C., Wei S. Multifunctional Immunoliposomes Combining Catalase and PD-L1 Antibodies Overcome Tumor Hypoxia and Enhance Immunotherapeutic Effects Against Melanoma. Int. J. Nanomed. 2020;15:1677\u20131691. doi: 10.2147/IJN.S225807.", "ArticleIdList": ["10.2147/IJN.S225807", "PMC7082626", "32214807"]}, {"Citation": "Friedl J.D., J\u00f6rgensen A.M., Le N.-M.N., Steinbring C., Bernkop-Schn\u00fcrch A. Replacing PEG-surfactants in self-emulsifying drug delivery systems: Surfactants with polyhydroxy head groups for advanced cytosolic drug delivery. Int. J. Pharm. 2022;618:121633. doi: 10.1016/j.ijpharm.2022.121633.", "ArticleIdList": ["10.1016/j.ijpharm.2022.121633", "35304244"]}, {"Citation": "Liu M., Zhao D., Yan N., Li J., Zhang H., Liu M., Tang X., Liu X., Deng Y., Song Y., et al. Evasion of the accelerated blood clearance phenomenon by branched PEG lipid derivative coating of nanoemulsions. Int. J. Pharm. 2022;612:121365. doi: 10.1016/j.ijpharm.2021.121365.", "ArticleIdList": ["10.1016/j.ijpharm.2021.121365", "34896215"]}, {"Citation": "Aldosari B.N., Alfagih I.M., Almurshedi A.S. Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines. Pharmaceutics. 2021;13:206. doi: 10.3390/pharmaceutics13020206.", "ArticleIdList": ["10.3390/pharmaceutics13020206", "PMC7913163", "33540942"]}, {"Citation": "Charbe N.B., Amnerkar N.D., Ramesh B., Tambuwala M.M., Bakshi H.A., Aljabali A.A.A., Khadse S.C., Satheeshkumar R., Satija S., Metha M., et al. Small interfering RNA for cancer treatment: Overcoming hurdles in delivery. Acta Pharm. Sin. B. 2020;10:2075\u20132109. doi: 10.1016/j.apsb.2020.10.005.", "ArticleIdList": ["10.1016/j.apsb.2020.10.005", "PMC7714980", "33304780"]}, {"Citation": "Alzhrani R., Alsaab H.O., Petrovici A., Bhise K., Vanamala K., Sau S., Krinock M.J., Iyer A.K. Improving the therapeutic efficiency of noncoding RNAs in cancers using targeted drug delivery systems. Drug Discov. Today. 2020;25:718\u2013730. doi: 10.1016/j.drudis.2019.11.006.", "ArticleIdList": ["10.1016/j.drudis.2019.11.006", "PMC7200292", "31758914"]}, {"Citation": "Mundra V., Mahato R.I. Design of nanocarriers for efficient cellular uptake and endosomal release of small molecule and nucleic acid drugs: Learning from virus. Front. Chem. Sci. Eng. 2014;8:387\u2013404. doi: 10.1007/s11705-014-1457-3.", "ArticleIdList": ["10.1007/s11705-014-1457-3"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "2", "Day": "23"}, {"Year": "2023", "Month": "3", "Day": "14"}, {"Year": "2023", "Month": "4", "Day": "27"}, {"Year": "2023", "Month": "5", "Day": "27", "Hour": "9", "Minute": "44"}, {"Year": "2023", "Month": "5", "Day": "27", "Hour": "9", "Minute": "43"}, {"Year": "2023", "Month": "5", "Day": "27", "Hour": "1", "Minute": "29"}, {"Year": "2023", "Month": "4", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["37242620", "PMC10221669", "10.3390/pharmaceutics15051379", "pharmaceutics15051379"]}}], "PubmedBookArticle": []}